Dasotraline Binge Eating Disorder Study
Clinical trial NCT02564588 · COMPLETED
Trial details
- NCT number
- NCT02564588
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.